论文部分内容阅读
目的对云南省新生儿疾病筛查进行成本-效益分析,探讨其社会经济效益。方法回顾性分析2012-2014年新生儿疾病筛查结果,参考相关统计数据,计算云南省新生儿疾病筛查的成本和效益。结果苯丙酮尿症(PKU)筛查和治疗成本为509 674元,效益为1 425 284元,成本-效益比1∶2.80;先天性甲状腺功能减低症(CH)筛查和治疗成本为142 335元,效益为1 412 453元,成本-效益比1∶9.92。新生儿疾病筛查项目综合成本为61 884 797元,综合效益421 591 037元,成本-效益比1∶6.81。结论云南省新生儿疾病筛查具有良好的社会和经济效益,值得进一步推广和应用。
Objective To carry out a cost-benefit analysis of neonatal screening in Yunnan Province to explore its social and economic benefits. Methods Retrospective analysis of 2012-2014 neonatal screening results, with reference to relevant statistics, calculate the cost and benefit of Yunnan neonatal screening. Results The cost of screening and treating phenylketonuria (PKU) was 509 674 yuan, the benefit was 1 425 284 yuan, and the cost-benefit ratio was 1:2.80. The screening and treatment cost of congenital hypothyroidism (CH) was 142 335 Yuan, with a benefit of 1 412 453 yuan and a cost-benefit ratio of 1:9.92. The comprehensive cost of newborn disease screening project was 61 884 797 yuan, the comprehensive benefit was 421 591 037 yuan, and the cost-benefit ratio was 1:6.81. Conclusion Neonatal screening in Yunnan Province has good social and economic benefits and should be further popularized and applied.